Withdrawal of Registration Statement (rw)
September 07 2018 - 8:02AM
Edgar (US Regulatory)
[LETTERHEAD OF NOVUS THERAPEUTICS, INC.]
September 7, 2018
VIA EDGAR
Securities and Exchange Commission
Division of
Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
|
Novus Therapeutics, Inc.
|
|
Request to Withdraw Registration Statement on Form
S-1
|
Ladies and Gentlemen:
Pursuant to Rule 477 of the Rules and
Regulations promulgated under the Securities Act of 1933, as amended (the
Securities Act Rules
), Novus Therapeutics, Inc., a Delaware corporation (the
Company
), hereby respectfully requests that the Securities
and Exchange Commission (the
Commission
) consent to the withdrawal of the above-referenced registration statement on Form
S-1
(the
Registration Statement
) together with
all exhibits thereto, and that such withdrawal be effective as of the date hereof or at the earliest practicable date hereafter. The Registration Statement was originally filed with the Commission on August 1, 2018.
The Company has determined not to undertake at this time the public offering to which the Registration Statement relates because of market conditions,
including valuation sensitivity at the current share price. The Registration Statement was not declared effective by the Commission, and the Company hereby confirms that no securities have been or will be sold pursuant to the Registration Statement.
The Company requests that, in accordance with Securities Act Rule 457(p), all fees paid to the Commission in connection with the filing of the
Registration Statement be credited for future use.
Thank you for your assistance with this matter. If you should have any questions regarding the
foregoing application for withdrawal or need anything further, please do not hesitate to contact me at (949)
238-8090
x705 or Ryan A. Murr of Gibson, Dunn & Crutcher LLP at (415)
393-8373.
Sincerely,
|
|
|
By:
|
|
/s/ Gregory J. Flesher
|
|
|
Chief Executive Officer
|
cc: Ryan A. Murr, Gibson Dunn & Crutcher LLP
Novus Therapeutics (NASDAQ:NVUS)
Historical Stock Chart
From Apr 2024 to May 2024
Novus Therapeutics (NASDAQ:NVUS)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Novus Therapeutics Inc (NASDAQ): 0 recent articles
More Novus Therapeutics, Inc. News Articles